IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Invivo Therapeutics Hldgs Co

CUSIP: 46186M209 | 122 institutional holders

Quarters

Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

Ladenburg Thalmann Financial Services Inc4,968
0.0% of portfolio›$3
StyleTurnoverLocationFiled
Ladenburg Thalmann Financial Services Inc
4,968$30.0%N/AN/AMiami, FL2018-08-15